Published date: Dec 31 2024

Journal Title: Journal of Ophthalmic and Vision Research

Issue title: Oct–Dec 2024, Volume 19, Issue 4

Pages: 392 – 396

DOI: 10.18502/jovr.v19i4.17786

Cameron F. Parsacfparsa@gmail.comErasmus Hospital, Université Libre de Bruxelles, Brussels, Belgium

This is an Editorial and does not have an abstract. Please download the PDF or view the article in HTML.

Keywords: Editorial

1. Benozzi G, Cortina ME, Gimeno E, Vantesone DL, Solas AE, Lorda GM, et al. A multicentric study of pharmacological treatment for presbyopia. Graefes Arch Clin Exp Ophthalmol 2021;259:2441–2450.

2. Montés-Micó R, Charman WN. Pharmacological strategies for presbyopia correction. J Refract Surg 2019;35:803– 814.

3. Waring GO 4th, Price FW Jr, Wirta D, McCabe C, Moshirfar M, Guo Q, et al. Safety and efficacy of AGN- 190584 in individuals with presbyopia: The GEMINI 1 Phase 3 randomized clinical trial. JAMA Ophthalmol 2022;140:363–371.

4. ClinicalTrials.gov. A phase 3 efficacy study of pilocarpine HCl ophthalmic solution (AGN-190584) in participants with presbyopia (GEMINI 2). https://clinicaltrials.gov/study/ NCT03857542?cond=NCT03857542&rank=1

5. Kannarr S, El-Harazi SM, Moshirfar M, Lievens C, Kim JL, Peace JH, et al. Safety and efficacy of twicedaily Pilocarpine HCl in presbyopia: The Virgo Phase 3, randomized, double-masked, controlled study. Am J Ophthalmol 2023;253:189–200.

6. Mousavi A, Rajavi Z, Sabbaghi H, Abdi S, Montazerin N, Kheiri B, et al. Pharmacological treatment of presbyopia using pilocarpine 1.25% eye drops. J Ophthalmic Vis Res 2024;4:468–475.

7. Eton EA, Zhao PY, Johnson MW, Rao RC, Huvard MJ. Rhegmatogenous retinal detachment after initiation of pilocarpine hydrochloride ophthalmic solution 1.25% for treatment of presbyopia. Retin Cases Brief Rep 2024;1;18:98–100.

8. Al-Khersan H, Flynn HW Jr, Townsend JH. Retinal detachments associated with topical pilocarpine use for presbyopia. Am J Ophthalmol 2022;242:52–55.

9. Josefson D. Healthy woman dies in research experiment. BMJ 2001;322:1565.

10. Kolata G. Johns Hopkins admits fault in fatal experiment. N Y Times Web 2001 Jul 17:A16.

11. Marshall E. Clinical research. Procedures faulted in fatal asthma trial. Science 2001;293:405–407.

12. Ogilvie RI. The death of a volunteer research subject: Lessons to be learned. CMAJ 2001;165:1335–1337.

13. Marshall E. Clinical research. Procedures faulted in fatal asthma trial. Science 2001;293:405–407.

14. Ogilvie RI. The death of a volunteer research subject: lessons to be learned. CMAJ 2001;165:1335–1337.

15. 72, Vol XI, 1969, p. 232-3, London: Kimpton.

16. Vogt A. Zystenbildung des Pupillarpigmentsaumes. Klin Mbl Augenheilk 1921;67;330.

17. Vogt, A. Weitere Ergebnisse der Spaltlampenmikroskopie des vorderen Bulbusabschnittes. Graefes Arhiv für Ophthalmologie 1923;111:91–127.

18. Berliner ML. Biomicroscopy of the eye: Slit lamp microscopy of the living eye. Paul B. Hoeber, Inc; 1949.

19. Chin NB, Gold AA, Breinin GM. Iris cysts and miotics. Arch Ophthalmol 1964;71:611–616.

20. Larsson S and Österlind G. Studies on the cause of senile miosis and rigidity of the pupil. Acta Ophthalmol (Copenh) 1944; 21:1–25.

21. Amarikwa L, Michalak SM, Caul S, Mruthyunjaya P, Rahimy E. Vitreofoveal traction associated with pilocarpine for presbyopia. Ophthalmic Surg Lasers Imaging Retina 2022;53:410–411.

22. Irvine SR. A newly defined vitreous syndrome following cataract surgery. Amer J Ophthal 1953;36:599–619.

23. Gass JD, Norton EW. Cystoid macular edema and papilledema following cataract extraction: A fluorescein fundoscopic and angiographic study. 1966. Retina 2003;23:646–661.

24. Tolentino FI, Schepens CL. Edema of posterior pole after cataract extraction. Arch Ophthal 1965;74:781–786.

25. Shaffer RN, Hetherington J Jr. Anticholinesterase drugs and cataracts. Trans Am Ophthalmol Soc 1966;64:204–216.

26. Michael R, Bron AJ. The ageing lens and cataract: a model of normal and pathological ageing. Philos Trans R Soc Lond B Biol Sci 2011;366:1278–1292.

27. Michael R, Barraquer RI, Willekens B, van Marle J, Vrensen, GFJM. Morphology of age-related cuneiform cortical cataracts: The case for mechanical stress. Vis Res 2008;48:626–634.

28. Fisher RF. Human lens fibre transparency and mechanical stress. Exp Eye Res 1973;16:41–49.

29. Pau H. Cortical and subcapsular cataracts: Significance of physical forces. Ophthalmologica 2006;220:1–5.

30. Harding CV, Susan SR, Lo W-K, Bobrowski WF, Maisel H, Chylack LT Jr. The structure of the human cataractous lens. In: Maisel H, editor. The ocular lens: Structure, function and pathology. New York: Marcel Dekker; 1985. Chap 10.

31. Croft MA, Heatley G, McDonald JP, Katz A, Kaufman PL. Accommodative movements of the lens/capsule and the strand that extends between the posterior vitreous zonule insertion zone & the lens equator, in relation to the vitreous face and aging. Ophthalmic Physiol Opt 2016;36:21–32.

32. Guyton DL. Accommodative amplitude measurements after surgery for presbyopia. In:

33. Tsubota K, Boxer Wachler BS, Azar DT, Koch DD, editors. Hyperopia and presbyopia. New York: Marcel Dekker, Inc; 2003.

34. Roche O, Roumes C, Parsa CF. Techniques de mesure du pouvoir accommodatif chez le sujet phake et le sujet pseudo-phake, distinction entre insuffisances accommodatives mécaniques et neurologiques [Techniques for measuring phakic and pseudophakic accommodation. Methodology for distinguishing between neurological and mechanical accommodative insufficiency]. J Fr Ophtalmol 2007;30:953–960.

35. Guyton DL, O’Connor GM. Dynamic retinoscopy. Curr Opin Ophthalmol 1991;2:78–80.

36. Wittgenstein L. Philosophical investigations. Anscombe GEM, editor. New York, The MacMillan Company, Part I, passage 329, 1953.

37. Parsa CF, Ellis FJ, Guyton DL. Photographic reproduction of out-of-focus and distorted ocular imagery. Vision Res 2001;41:1489–1499.

38. Donders FC. On the anomalies of accommodation and refraction of the eye. London: New Sydenham Society 1864;610–621.

39. Charman WN. Pinholes and presbyopia: Solution or sideshow? Ophthalmic Physiol Opt 2019;39:1–10.

40. Parsa CF. Accommodative spasm. In: Fraunfelder FT, Roy FH, editors. Current ocular therapy. 6th ed. Philadelphia, W.B. Saunders Company; 2008. p. 517–518.

41. Waring GO 4th, Brujic M, McGee S, Micheletti JM, Zhao C, Schachter S, et al. Impact of presbyopia treatment pilocarpine hydrochloride 1.25% on night-driving performance. Clin Exp Optom 2024;107:665–672.

42. Breyer A, Jiang X, Rütsche A, Bieri H, Oexl T, Baumann A, et al. Influence of the Pulfrich phenomenon on driving performance. Graefe’s Arch Clin Exp Ophthalmol 2006;244:1555–1561.

43. Plainis S, Petratou D, Giannakopoulou T, Radhakrishnan H, Pallikaris IG, Charman WN. Small-aperture monovision and the Pulfrich experience: Absence of neural adaptation effects. PLoS One 2013;8:e75987.

44. McGowan G, Ahmed TY, Heron G, Diaper C. The Pulfrich phenomenon; Clumsiness and collisions which can be ameliorated. Pract Neurol 2011;11:173–176.